Cryptosporidium parvum has an active hypusine biosynthesis pathway

Nimisha Mittal1, Marie Morada2, Pankaj Tripathi1

  • 1School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.

Insights

Cryptosporidium parvum causes severe diarrheal disease. Researchers identified and characterized the parasite's deoxyhypusine synthase (DHS) enzyme, finding it a potential drug target. Inhibition of CpDHS effectively reduced parasite growth.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Biochemistry

Background:

  • Cryptosporidium parvum causes significant diarrheal disease, especially in immunocompromised individuals and children.
  • No fully effective treatments are currently available for cryptosporidiosis.
  • Hypusination of eIF5A, a process involving deoxyhypusine synthase (DHS), is crucial for cell proliferation.

Purpose of the Study:

  • To identify and characterize the Cryptosporidium parvum deoxyhypusine synthase (CpDHS) enzyme.
  • To investigate CpDHS as a potential drug target for treating cryptosporidiosis.
  • To explore the mechanism, structure, and inhibition profile of CpDHS.

Main Methods:

  • Identification and cloning of the CpDHS gene.
  • Recombinant protein expression, purification, and kinetic analysis.
  • Sequence analysis, structural modeling, and phylogenetic studies.
  • In vitro inhibition assays using N(1)-guanyl-1,7-diaminoheptane (GC7).

Main Results:

  • A single gene encoding CpDHS was identified, with the recombinant protein purified.
  • CpDHS shares conserved functional residues with human DHS, indicating potential for targeted inhibition.
  • Phylogenetic analysis places CpDHS closer to apicomplexan DHS than kinetoplastid DHS.
  • The DHS inhibitor GC7 effectively inhibited C. parvum infection and growth in HCT-8 cells.

Conclusions:

  • CpDHS is a viable drug target for treating Cryptosporidium parvum infections.
  • Inhibiting CpDHS offers a promising therapeutic strategy against cryptosporidiosis.
  • Further research into CpDHS inhibitors could lead to effective treatments for this disease.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
780
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.8K
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
1.7K
Other Glycolytic Pathways01:24

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
1.1K
Biosynthesis of Polysaccharides01:26

Biosynthesis of Polysaccharides

Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
983
Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
2.3K